Why Stock Matters: Your Complete Treatment Timeline
Wegovy vs Mounjaro UK: Understanding the Complete Dose Escalation
When comparing Wegovy vs Mounjaro UK availability, the most critical factor is securing every dose for your treatment journey. Wegovy follows a structured 20-week escalation: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), and 2.4mg maintenance from week 17 onwards. This gradual increase is mandatory—you cannot skip doses or accelerate the timeline without risking side effects. Mounjaro uses a different approach with 2.5mg starting doses, escalating to 5mg, 7.5mg, 10mg, 12.5mg, and 15mg maximum, with each dose maintained for at least 4 weeks.
The key difference in Wegovy vs Mounjaro UK treatment planning is duration commitment. Most patients remain on 2.4mg Wegovy indefinitely for weight maintenance, meaning you'll need reliable access to this prescription-only medicine long-term. EverydayMeds stocks every dose consistently, eliminating the frustration of switching pharmacies mid-treatment when other suppliers run short of specific strengths.
Pricing Transparency: Wegovy vs Mounjaro UK Cost Comparison
Understanding the full cost of Wegovy vs Mounjaro UK treatment requires looking beyond just starter prices. Wegovy single pens cost £79.99 for 0.25mg, £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose—with discount codes FIRST40 for new customers and DOSE25 for returning customers applied at checkout. Our Intro Trio bundle (0.25mg, 0.5mg, 1mg) provides your first 12 weeks for £299.99, while the Ultimate Stability Trio offers three months of 2.4mg maintenance supply for £649.99.
Mounjaro pricing follows a different structure, with higher-strength doses commanding premium prices due to the dual GIP/GLP-1 mechanism. When calculating long-term costs for Wegovy vs Mounjaro UK treatment, consider that most patients reach Wegovy's maximum 2.4mg dose and remain there, while Mounjaro patients may require titration to 10mg, 12.5mg, or even 15mg for optimal results, significantly impacting monthly treatment costs.
Clinical Evidence: How Wegovy vs Mounjaro UK Trials Compare
The landmark STEP trials demonstrated that patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). STEP 5 data showed sustained clinically studied weight loss maintained at 2 years, establishing Wegovy's long-term efficacy profile. These results were achieved specifically with the 2.4mg maintenance dose following proper escalation.
Mounjaro's SURMOUNT trials showed different efficacy patterns due to its dual incretin approach, but direct comparison between Wegovy vs Mounjaro UK results requires careful interpretation since the studies used different populations, endpoints, and methodologies. Both treatments require ongoing use alongside a reduced-calorie diet and increased physical activity—weight regain occurs when treatment stops, with patients typically regaining two-thirds of lost weight within one year of discontinuation.
Mechanism Deep-Dive: Wegovy vs Mounjaro UK Action Differences
The fundamental difference in Wegovy vs Mounjaro UK mechanisms centres on receptor targeting. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your natural incretin hormone, reducing appetite and promoting satiety after smaller meals. It works primarily on brain appetite centres, slowing gastric emptying and reducing food cravings. Mounjaro (tirzepatide) takes a dual approach, activating both GLP-1 and GIP receptors simultaneously, potentially offering enhanced glucose control and weight loss through complementary pathways. Both are administered as once-weekly subcutaneous injections, but the dual mechanism may explain why some patients respond better to Mounjaro despite Wegovy's proven efficacy.
Ordering Process: Seamless Wegovy vs Mounjaro UK Access
Securing either treatment through EverydayMeds follows our streamlined three-step process, regardless of whether you choose Wegovy or Mounjaro after clinical assessment. Complete our 3-minute online questionnaire detailing your weight management history, current medications, and treatment goals. Your responses are reviewed by our GPhC-registered prescribers within 3 working days (or 24 hours with express service), who determine suitability and recommend starting doses. Once approved, we dispatch your prescription-only medicine via next-day cold-chain delivery, maintaining the 2-8°C temperature requirements throughout transit. Our pharmacy registration number GPhC #9012878 ensures full regulatory compliance and quality assurance.
Storage and Practical Considerations: Wegovy vs Mounjaro UK Daily Life
Both treatments require refrigerated storage at 2-8°C before first use, but Wegovy offers superior travel flexibility with 6 weeks room temperature tolerance (below 30°C) compared to Mounjaro's 21-day limit. This advantage makes Wegovy more practical for frequent travellers or those with unreliable refrigeration access. Both use simple pre-filled pens—Wegovy's FlexTouch and Mounjaro's KwikPen—requiring no mixing or preparation. The injection technique is identical, with most patients rotating between thigh, upper arm, and abdomen sites weekly. Dose escalation timing is critical for both treatments, with premature increases risking nausea, vomiting, and treatment discontinuation.
Supply Security: Why Complete Wegovy vs Mounjaro UK Inventory Matters
The most overlooked aspect of Wegovy vs Mounjaro UK treatment planning is supply continuity over months or years. Many patients start treatment only to discover their pharmacy lacks specific doses, forcing treatment interruptions or pharmacy switches mid-escalation. Missing even one week can necessitate restarting from lower doses, extending your journey to maintenance therapy. EverydayMeds maintains comprehensive inventory across all strengths, from starter doses through maximum maintenance levels.
Our Step-up bundles anticipate your progression needs, with the Progress Trio covering months 2-4 of treatment and the Elevate Trio bridging you to maintenance dosing. This forward-planning approach eliminates supply anxiety and ensures consistent treatment progression whether you're prescribed Wegovy or Mounjaro following clinical assessment.
Making Your Decision: Expert Wegovy vs Mounjaro UK Guidance
Your choice between Wegovy vs Mounjaro UK treatments should be guided by clinical factors, not just availability or cost considerations. Our prescribers evaluate your BMI, comorbidities, previous weight loss attempts, and current medications to recommend the most suitable option. Both treatments are available from EverydayMeds with complete dose ranges in stock—your prescriber can help determine which aligns best with your individual circumstances and treatment goals. Start your clinical assessment today using discount code FIRST40 at checkout, knowing that whichever treatment you're prescribed, we have every dose ready for next-day delivery from our GPhC-registered pharmacy.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
